Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyagertm DSLT, the first and only Direct ...

There was a notable decrease in common ophthalmic procedures among Medicare beneficiaries during the first year of the COVID-19 pandemic, according to a study published Feb. 6 in JAMA Ophthalmology.

Introduction:The Global Allergy Immunotherapy Market is valued at USD 1.63 Billion in 2022 and is projected to reach a value ...